腫瘍栄養学の世界市場：2025年～2033年

腫瘍栄養学の世界市場は、2024年に24億6,000万米ドルに達し、2033年までには53億3,000万米ドルに達すると予測され、予測期間中の2025年から2033年のCAGRは8.8%で成長する見込みです。

世界の腫瘍栄養学市場は、がん患者の治療過程全体をサポートするために設計された、特殊な栄養製品とサービスを提供することに特化した業界を指します。この市場には、栄養補助食品、経腸栄養製品、治療用食品など、化学療法、放射線療法、その他のがん治療を受けている患者特有の栄養ニーズに対応することを目的としたさまざまな製品が含まれます。

がん治療は、栄養不良、体重減少、食欲の変化などの合併症を引き起こすことが多いです。腫瘍栄養学市場は、このような問題の管理に役立つ製品の開発に重点を置いており、患者が全体的な健康と治療成果をサポートするために十分な栄養を摂取できるようにしています。腫瘍栄養学の世界市場は、がん患者のQOL（生活の質）と治療成績の向上を目指した専門的な食事療法を提供することで、がん患者のサポートに重要な役割を果たしています。がん治療における栄養の重要性に対する認識が高まるにつれて、同市場は継続的な成長と革新の態勢を整えています。こうした要因が、世界の腫瘍栄養学市場の拡大を牽引しています。

市場力学：

促進要因と抑制要因

腫瘍栄養学製品の技術革新

腫瘍栄養学製品のイノベーションは、世界の腫瘍栄養学市場の成長を大きく牽引しており、市場予測期間中も牽引していくと予想されます。腫瘍栄養学市場は、個々の患者のニーズに応える個別化栄養プランの研究が進んでいることから、今後も拡大が続くと予想されます。製品開発におけるイノベーションは、がん治療中の栄養サポートの有効性を高めることに重点が置かれるとみられます。

腫瘍栄養学製品の技術革新は、がん患者の食事サポートを強化する進歩に焦点を当てており、世界の腫瘍栄養学市場の重要な推進力となっています。これらの技術革新は、がん治療を受けている患者が直面する特定の栄養課題に取り組み、最終的に患者のQOLと治療成績を改善することを目的としています。

がん患者特有のニーズに合わせた個別化栄養製品の開発がますます重視されるようになっています。例えば、Talityのような製品はTargeted Nutrients Deprivation（TND）と呼ばれる概念を利用しており、がん細胞から非必須アミノ酸を奪う一方で、健康な細胞には必須栄養素を供給します。このアプローチは細胞代謝に関する広範な研究に基づくもので、治療効果を高め、患者の転帰を改善することを目的としています。

3Dプリンティングなどの最先端技術の統合は、がん患者向けの栄養製品の開発に革命をもたらしています。この技術により、嚥下障害（飲み込みにくさ）などの特定の食事制限に対応したオーダーメイドの食事を作ることができ、患者が摂取しやすい形で十分な栄養を摂取できるようになります。

さらに、世界の腫瘍栄養学市場の成長を促進するパートナーシップやコラボレーションなどの主要企業の戦略も挙げられます。例えば、2024年6月、原子力省（DAE）はIDRS Labs Pvt. Ltd.と共同で開発したAKTOCYTEという革新的な栄養補助食品を発表しました。この革新的な食品サプリメントは、放射線治療を受けているがん患者の生活の質を高めるために特別に処方されたものです。これらすべての要因が、世界の腫瘍栄養学市場に需要をもたらしています。

さらに、個人に合わせた栄養計画の開発需要の高まりも、世界の腫瘍栄養学市場の拡大に寄与しています。

個人の限られた意識

腫瘍栄養学の世界市場では、がん治療における栄養の重要な役割について患者と一般大衆の双方に影響を及ぼす個人間の認識不足が大きな抑制要因となっています。この認識不足は、がん患者に対する効果的な栄養サポートの妨げとなるいくつかの課題につながります。

多くのがん患者は、治療や回復過程において栄養が果たす重要な役割を十分に理解していない可能性があります。その結果、必要な食事の変更を見落としたり、治療の副作用の管理、体力の維持、全般的な健康増進に役立つ専門的な栄養製品を求めなかったりすることがあります。このような栄養不足は、回復を妨げ、治療結果に悪影響を及ぼす可能性があります。

患者はしばしば、がん治療中に必要とされる具体的な栄養について明確になっていません。例えば、特定の食品やサプリメントが吐き気や疲労などの症状をどのように緩和するのか理解していない場合があります。このような誤解が、病状を悪化させ回復を妨げるような不適切な食事の選択につながることがあります。したがって、上記のような要因が世界の腫瘍栄養学市場の潜在的成長を制限している可能性があります。

目次

第1章 調査手法と調査範囲

第2章 定義と概要

第3章 エグゼクティブサマリー

第4章 市場力学

• 影響要因
  • 促進要因
    • 腫瘍栄養製品のイノベーション
  • 抑制要因
    • 個人間の認識の限界
  • 機会
  • 影響分析

第5章 産業分析

• ポーターのファイブフォース分析
• サプライチェーン分析
• 価格分析
• 特許分析
• 規制分析
• SWOT分析
• アンメットニーズ

第6章 がんタイプ別

• 血液がん
• 乳がん
• 胃がん・消化器がん
• 肝臓がん
• 膵臓がん
• 肺がん
• 頭頸部がん
• その他

第7章 エンドユーザー別

• 病院
• 在宅医療
• その他

第8章 地域別

• 北米
  • 米国
  • カナダ
  • メキシコ
• 欧州
  • ドイツ
  • 英国
  • フランス
  • スペイン
  • イタリア
  • その他欧州地域
• 南米
  • ブラジル
  • アルゼンチン
  • その他南米
• アジア太平洋
  • 中国
  • インド
  • 日本
  • 韓国
  • その他アジア太平洋
• 中東・アフリカ

第9章 競合情勢

• 競合シナリオ
• 市況・シェア分析
• M&A分析

第10章 企業プロファイル

• Nestle Health Science
  • 会社概要
  • 製品ポートフォリオ
    • 製品説明
    • 製品の主要業績評価指標（KPI）
    • 過去および予測の製品販売
    • 製品販売量
  • 財務概要
    • 会社の収益
    • 地域別収益分配
    • 収益予測
  • 主な発展
    • 合併と買収
    • 主な製品開発活動
    • 規制当局の承認等
  • SWOT分析
• Abbott
• Danone
• Fresenius Kabi India Pvt.
• B. Braun SE
• Lyons Health Labs.
• Global Health Products, Inc.
• Esperer Nutrition.

第11章 付録

The global oncology nutrition market reached US$ 2.46 billion in 2024 and is expected to reach US$ 5.33 billion by 2033, growing at a CAGR of 8.8 % during the forecast period 2025-2033.

The global oncology nutrition market refers to the industry dedicated to providing specialized nutritional products and services designed to support cancer patients throughout their treatment journey. This market encompasses a variety of offerings, including dietary supplements, enteral nutrition products, and therapeutic foods, all aimed at addressing the unique nutritional needs of individuals undergoing chemotherapy, radiotherapy, or other cancer treatments.

Cancer treatments often lead to complications such as malnutrition, weight loss, and appetite changes. The oncology nutrition market focuses on developing products that help manage these issues, ensuring that patients receive adequate nutrition to support their overall health and treatment outcomes. The global oncology nutrition market plays a crucial role in supporting cancer patients by providing specialized dietary solutions aimed at improving their quality of life and treatment outcomes. As awareness grows regarding the significance of nutrition in cancer care, this market is poised for continued growth and innovation. These factors have driven the global oncology nutrition market expansion.

Market Dynamics: Drivers & Restraints

Innovations in Oncology Nutritional Products

The innovations in oncology nutritional products is significantly driving the growth of the global oncology nutrition market and is expected to drive throughout the market forecast period. The oncology nutrition market is expected to continue expanding due to ongoing research into personalized nutrition plans that cater to individual patient needs. Innovations in product development are likely to focus on enhancing the effectiveness of nutritional support during cancer treatment.

Innovations in oncology nutritional products are a crucial driving force in the global oncology nutrition market, focusing on advancements that enhance dietary support for cancer patients. These innovations aim to tackle the specific nutritional challenges faced by individuals undergoing cancer treatment, ultimately improving their quality of life and treatment outcomes.

There is an increasing emphasis on developing personalized nutrition products tailored to the unique needs of cancer patients. For instance, products like Tality utilize a concept known as Targeted Nutrients Deprivation (TND), which deprives cancer cells of non-essential amino acids while supplying essential nutrients to healthy cells. This approach is grounded in extensive research into cell metabolism and aims to enhance treatment efficacy and improve patient outcomes.

The integration of cutting-edge technologies, such as 3D printing, is revolutionizing the development of nutritional products for cancer patients. This technology allows for the creation of customized meals that accommodate specific dietary restrictions, such as dysphagia (difficulty swallowing), ensuring that patients receive adequate nutrition in a form they can easily consume.

Furthermore, key players strategies such as partnerships and collaborations that would drive this global oncology nutrition market growth. For instance, in June 2024, the Department of Atomic Energy (DAE) unveiled an innovative nutraceutical called AKTOCYTE, developed in collaboration with IDRS Labs Pvt. Ltd. This innovative food supplement is specifically formulated to enhance the quality of life for cancer patients undergoing radiotherapy. All these factors demand the global oncology nutrition market.

Moreover, the rising demand for the growth of development of personalized nutrition plans contributes to the global oncology nutrition market expansion.

Limited Awareness among Individuals

Limited awareness among individuals presents a significant restraint in the global oncology nutrition market, affecting both patients and the general public regarding the critical role of nutrition in cancer care. This lack of awareness can lead to several challenges that hinder effective nutritional support for cancer patients:

Many cancer patients may not fully understand the vital role that nutrition plays in their treatment and recovery processes. Consequently, they might overlook necessary dietary changes or fail to seek specialized nutritional products that could help manage treatment side effects, maintain strength, and enhance overall health. This underutilization can impede their recovery and negatively impact treatment outcomes.

Patients often lack clarity about their specific nutritional requirements during cancer treatment. For instance, they may not realize how certain foods or supplements can alleviate symptoms such as nausea or fatigue. This misunderstanding can result in poor dietary choices that exacerbate their condition and hinder recovery. Thus, the above factors could be limiting the global oncology nutrition market's potential growth.

Segment Analysis

The global oncology nutrition market is segmented based on cancer type, end-user, and region.

Cancer Type:

The Head and Neck Cancers segment is expected to dominate the global oncology nutrition market share

The head and neck cancers segment holds a major portion of the global oncology nutrition market share and is expected to continue to hold a significant portion of the global oncology nutrition market share during the forecast period. The global oncology nutrition market is crucial due to the specific nutritional challenges faced by patients diagnosed with these types of cancers. This segment focuses on providing specialized nutritional support tailored to the unique needs of individuals with head and neck cancers, which encompass cancers of the oral cavity, pharynx, larynx, and salivary glands.

Patients with head and neck cancers often experience significant nutritional difficulties as a result of treatment side effects. These challenges include difficulty swallowing can make it painful or impossible for patients to consume solid foods, necessitating a shift to softer diets or enteral nutrition. Treatments such as chemotherapy and radiation can alter taste perception, leading to decreased appetite and food intake.

Inflammation of the mucous membranes can cause pain and discomfort while eating, complicating nutritional intake further. Proper nutrition is essential for maintaining strength, supporting immune function, and improving overall quality of life during cancer treatment. Nutritional interventions can help mitigate treatment side effects, prevent malnutrition, and enhance recovery.

Furthermore, key players in the industry focus on the research activities that would drive this segment growth in the global oncology nutrition market. For instance, according to the S. Karger AG, Bas research data in July 2024, zinc supplementation has emerged as a promising approach to alleviate complications arising from chemotherapy and radiotherapy in patients with head and neck cancer. This interest in zinc is due to its essential role as a trace element that supports various cellular functions, including immune response and tissue repair.

Research indicates that zinc may provide protective benefits to normal tissues, particularly the salivary glands, during radiation therapy. This is important because radiotherapy often leads to side effects such as xerostomia (dry mouth) and mucositis (inflammation of the mucous membranes), which can significantly impact a patient's quality of life. These factors have solidified the segment's position in the global oncology nutrition market.

Geographical Analysis

North America is expected to hold a significant position in the global oncology nutrition market share

North America holds a substantial position in the global oncology nutrition market and is expected to hold most of the market share. The incidence of cancer in North America is on the rise, with estimates suggesting approximately 1.9 million new cancer cases diagnosed in the United States in 2022. This growing patient population creates a heightened demand for nutritional support tailored to the specific needs of cancer patients, as proper nutrition is essential for managing treatment side effects and improving overall health outcomes.

North America benefits from a well-established healthcare system that includes advanced medical facilities, access to specialized care, and a strong emphasis on patient-centered approaches. This infrastructure facilitates the integration of oncology nutrition into comprehensive cancer care, making it easier for patients to access nutritional products and services. There is a growing recognition among healthcare professionals and patients regarding the importance of nutrition in cancer treatment and recovery. Educational initiatives, such as symposiums and certification programs offered by organizations like the Oncology Nutrition Institute, are helping to raise awareness about effective nutritional strategies, further driving demand for oncology nutrition products.

Various government programs aim to enhance cancer care and support research into oncology nutrition. These initiatives often promote awareness campaigns and provide funding for nutritional research, which can lead to the development of innovative products tailored to meet cancer patients' needs. Furthermore, a major number of key players presence, and investments that would drive this global oncology nutrition market growth.

For instance, in June 2022, Faeth Therapeutics, a company specializing in cancer metabolism, successfully completed a $47 million Series A funding round led by S2G Ventures. This financing brings the total funding raised by the company to $67 million. The funds will be utilized to progress Faeth's clinical trials, which focus on integrating nutrient control, therapeutic strategies, and digital tools to inhibit cancer metabolism. Thus, the above factors are consolidating the region's position as a dominant force in the global oncology nutrition market.

Asia Pacific is growing at the fastest pace in the global oncology nutrition market share

Asia Pacific holds the fastest pace in the global oncology nutrition market and is expected to hold most of the market share.

The Asia-Pacific (APAC) oncology nutrition market is positioned for significant growth, driven by various factors that reflect the region's evolving healthcare landscape and the increasing prevalence of cancer. The APAC region is experiencing a notable rise in cancer cases, with projections suggesting that this trend will continue. The growing patient population creates a heightened demand for specialized nutritional support tailored to the unique needs of cancer patients. Proper nutrition is essential for managing treatment side effects and improving overall health outcomes, leading to increased utilization of oncology nutrition products.

Many countries in the APAC region are investing in their healthcare infrastructure, resulting in better access to medical facilities and specialized care. Enhanced healthcare systems facilitate the integration of oncology nutrition into comprehensive cancer care, ensuring that patients can easily access necessary nutritional products and services. There is a growing recognition among healthcare professionals and patients regarding the importance of nutrition in cancer treatment and recovery. Educational initiatives, including workshops and training programs, are helping to raise awareness about effective nutritional strategies, thereby driving demand for oncology nutrition products.

Furthermore, key players in the industry in the industry product launches that would drive this global oncology nutrition market growth. For instance, in July 2022, Nestle introduced China's first Foods for Special Medical Purpose (FSMP) tailored for patients with tumor-related conditions, completing a comprehensive five-year approval process with Chinese regulatory authorities. This innovative product, named Oral Impact Su Yi Su, stands out as the only FSMP currently authorized for nutritional supplementation within this patient demographic. Thus, the above factors are consolidating the region's position as the fastest-growing force in the global oncology nutrition market.

Competitive Landscape

The major global players in the oncology nutrition market include Nestle Health Science, Abbott, Danone, Fresenius Kabi India Pvt., B. Braun SE, Lyons Health Labs., Global Health Products, Inc., and Esperer Nutrition., among others.

Key Developments

• In June 2024, AEACaP (Asociacion Espanola de Afectados de Cancer de Pulmon) launched an initiative called "Pills About Nutrition," which consists of a series of educational videos aimed at providing crucial nutritional guidance for lung cancer patients, their families, and caregivers. This program underscores AEACaP's dedication to enhancing the quality of life for individuals impacted by lung cancer through informed dietary choices.

Why Purchase the Report?

• Pipeline & Innovations: Reviews ongoing clinical trials, and product pipelines, and forecasts upcoming advancements in medical devices and pharmaceuticals.
• Product Performance & Market Positioning: Analyzes product performance, market positioning, and growth potential to optimize strategies.
• Real-World Evidence: Integrates patient feedback and data into product development for improved outcomes.
• Physician Preferences & Health System Impact: Examines healthcare provider behaviors and the impact of health system mergers on adoption strategies.
• Market Updates & Industry Changes: Covers recent regulatory changes, new policies, and emerging technologies.
• Competitive Strategies: Analyzes competitor strategies, market share, and emerging players.
• Pricing & Market Access: Reviews pricing models, reimbursement trends, and market access strategies.
• Market Entry & Expansion: Identifies optimal strategies for entering new markets and partnerships.
• Regional Growth & Investment: Highlights high-growth regions and investment opportunities.
• Supply Chain Optimization: Assesses supply chain risks and distribution strategies for efficient product delivery.
• Sustainability & Regulatory Impact: Focuses on eco-friendly practices and evolving regulations in healthcare.
• Post-market Surveillance: Uses post-market data to enhance product safety and access.
• Pharmacoeconomics & Value-Based Pricing: Analyzes the shift to value-based pricing and data-driven decision-making in R&D.

The global oncology nutrition market report delivers a detailed analysis with 60+ key tables, more than 50 visually impactful figures, and 176 pages of expert insights, providing a complete view of the market landscape.

Target Audience 2023

• Manufacturers: Pharmaceutical, Medical Device, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
• Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
• Technology & Innovation: AI/Robotics Providers, R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
• Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
• Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
• Supply Chain: Distribution and Supply Chain Managers.
• Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.
• Academic & Research: Academic Institutions.

Table of Contents

1. Methodology and Scope

• 1.1. Research Methodology
• 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

• 3.1. Snippet by Cancer Type
• 3.2. Snippet by End-User
• 3.3. Snippet by Region

4. Dynamics

• 4.1. Impacting Factors
  • 4.1.1. Drivers
    • 4.1.1.1. Innovations in Oncology Nutritional Products
  • 4.1.2. Restraints
    • 4.1.2.1. Limited Awareness among Individuals
  • 4.1.3. Opportunity
  • 4.1.4. Impact Analysis

5. Industry Analysis

• 5.1. Porter's Five Force Analysis
• 5.2. Supply Chain Analysis
• 5.3. Pricing Analysis
• 5.4. Patent Analysis
• 5.5. Regulatory Analysis
• 5.6. SWOT Analysis
• 5.7. Unmet Needs

6. By Cancer Type

• 6.1. Introduction
  • 6.1.1. Analysis and Y-o-Y Growth Analysis (%), By Cancer Type
  • 6.1.2. Market Attractiveness Index, By Cancer Type
• 6.2. Blood Cancer*
  • 6.2.1. Introduction
  • 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 6.3. Breast Cancer
• 6.4. Stomach and Gastrointestinal Cancers
• 6.5. Liver Cancer
• 6.6. Pancreatic Cancer
• 6.7. Lung Cancer
• 6.8. Head and Neck Cancers
• 6.9. Others

7. By End-User

• 7.1. Introduction
  • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
  • 7.1.2. Market Attractiveness Index, By End-User
• 7.2. Hospitals *
  • 7.2.1. Introduction
  • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 7.3. Homecare Settings
• 7.4. Others

8. By Region

• 8.1. Introduction
  • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
  • 8.1.2. Market Attractiveness Index, By Region
• 8.2. North America
  • 8.2.1. Introduction
  • 8.2.2. Key Region-Specific Dynamics
  • 8.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Cancer Type
  • 8.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
  • 8.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 8.2.5.1. U.S.
    • 8.2.5.2. Canada
    • 8.2.5.3. Mexico
• 8.3. Europe
  • 8.3.1. Introduction
  • 8.3.2. Key Region-Specific Dynamics
  • 8.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Cancer Type
  • 8.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
  • 8.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 8.3.5.1. Germany
    • 8.3.5.2. U.K.
    • 8.3.5.3. France
    • 8.3.5.4. Spain
    • 8.3.5.5. Italy
    • 8.3.5.6. Rest of Europe
• 8.4. South America
  • 8.4.1. Introduction
  • 8.4.2. Key Region-Specific Dynamics
  • 8.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Cancer Type
  • 8.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
  • 8.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 8.4.5.1. Brazil
    • 8.4.5.2. Argentina
    • 8.4.5.3. Rest of South America
• 8.5. Asia-Pacific
  • 8.5.1. Introduction
  • 8.5.2. Key Region-Specific Dynamics
  • 8.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Cancer Type
  • 8.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
  • 8.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 8.5.5.1. China
    • 8.5.5.2. India
    • 8.5.5.3. Japan
    • 8.5.5.4. South Korea
    • 8.5.5.5. Rest of Asia-Pacific
• 8.6. Middle East and Africa
  • 8.6.1. Introduction
  • 8.6.2. Key Region-Specific Dynamics
  • 8.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Cancer Type
  • 8.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User

9. Competitive Landscape

• 9.1. Competitive Scenario
• 9.2. Market Positioning/Share Analysis
• 9.3. Mergers and Acquisitions Analysis

10. Company Profiles

• 10.1. Nestle Health Science*
  • 10.1.1. Company Overview
  • 10.1.2. Product Portfolio
    • 10.1.2.1. Product Description
    • 10.1.2.2. Product Key Performance Indicators (KPIs)
    • 10.1.2.3. Historic and Forecasted Product Sales
    • 10.1.2.4. Product Sales Volume
  • 10.1.3. Financial Overview
    • 10.1.3.1. Company Revenue's
    • 10.1.3.2. Geographical Revenue Shares
    • 10.1.3.3. Revenue Forecasts
  • 10.1.4. Key Developments
    • 10.1.4.1. Mergers & Acquisitions
    • 10.1.4.2. Key Product Development Activities
    • 10.1.4.3. Regulatory Approvals etc.
  • 10.1.5. SWOT Analysis
• 10.2. Abbott
• 10.3. Danone
• 10.4. Fresenius Kabi India Pvt.
• 10.5. B. Braun SE
• 10.6. Lyons Health Labs.
• 10.7. Global Health Products, Inc.
• 10.8. Esperer Nutrition.

LIST NOT EXHAUSTIVE

11. Appendix

• 11.1. About Us and Services
• 11.2. Contact Us